American Journal of Epidemiology Vol. 135, No. 11: 1220-1230
Copyright © 1992 by The Johns Hopkins University School of Hygiene and Public Health
research-article |
Sex Hormones and Postmenopausal Breast Cancer: A Prospective Study in an Adult Community
From the Division of Epidemiology, Department of Community and Family Medicine, School of Medicine, University of California San Diego, La Jolla, CA
Reprint request to Dr Cedric F. Garland, Division of Epidemiology, 0607, Department of Community and Family Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093–0607
Few studies have examined the role of endogenous sex hormones in breast cancer, and to the authors' knowledge, only two have done so prospectively. The authors report here the results of a prospective study based on an available bank of previously analyzed plasma collected in 1972–1974 from 442 women aged 50–79 years in Rancho Bernardo, California. These women were followed for 12–15 years, during which time 42 cases of breast cancer were identified: 15 incident cases diagnosed 1 year or more after baseline, 18 prevalent cases diagnosed earlier than 1 year after baseline, and 9 cases with unknown dates of onset. No apparent trends in plasma levels of sex hormones or sex hormone-binding globulin and incidence or prevalence of breast cancer were observed. Mean crude and age-adjusted plasma hormone levels at baseline (in pg/ml) for incident cases, total cases, and noncases, respectively, were: androstene-dione: 647, 638 ± 328 (standard deviation); 626, 620 ± 245; and 664, 664 ± 291; testosterone: 254, 258 ± 120; 238, 241 ± 153; and 262, 261 ± 143; estrone: 37, 38 ± 18; 35, 35 ± 15; and 37, 37 ± 17; and estradiol: 13, 13 ± 7; 15, 15 ± 8; and 15, 15 ± 9. For sex hormone-binding globulin, mean crude and age-adjusted levels at baseline (nM) were 35 and 36 ± 33 for incident cases; 31 and 31 ± 25 for total cases; and 29 and 29 ± 21 for noncases. Cox proportional hazards multiple regression showed no associations with breast cancer after simultaneous adjustment for age, body mass index, and cigarette smoking. Am J Epidemiol 1992; 135: 1220–30
androstenedlone; breast neoplasms; estrogens; prospective studies; sex hormone-binding globulin; testosterone
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. B. Ness, J. D. Albano, A. McTiernan, and J. A. Cauley Influence of Estrogen Plus Testosterone Supplementation on Breast Cancer Arch Intern Med, January 12, 2009; 169(1): 41 - 46. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. D. Braunstein, B. D. Johnson, F. Z. Stanczyk, V. Bittner, S. L. Berga, L. Shaw, T. K. Hodgson, M. Paul-Labrador, R. Azziz, and C. N. B. Merz Relations between Endogenous Androgens and Estrogens in Postmenopausal Women with Suspected Ischemic Heart Disease J. Clin. Endocrinol. Metab., November 1, 2008; 93(11): 4268 - 4275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Xue and K. B Michels Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence Am. J. Clinical Nutrition, September 1, 2007; 86(3): 823S - 835S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Morton, D. Kritz-Silverstein, D. J. Riley, E. L. Barrett-Connor, and D. L. Wingard Premature Graying, Balding, and Low Bone Mineral Density in Older Women and Men: The Rancho Bernardo Study J Aging Health, April 1, 2007; 19(2): 275 - 285. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Russo, S. V. Fernandez, P. A. Russo, R. Fernbaugh, F. S. Sheriff, H. M. Lareef, J. Garber, and I. H. Russo 17-Beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells FASEB J, August 1, 2006; 20(10): 1622 - 1634. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. H. Eliassen, S. A. Missmer, S. S. Tworoger, and S. E. Hankinson Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer: Does the Association Vary by a Woman's Predicted Breast Cancer Risk? J. Clin. Oncol., April 20, 2006; 24(12): 1823 - 1830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Kaaks, S Rinaldi, T J Key, F Berrino, P H M Peeters, C Biessy, L Dossus, A Lukanova, S Bingham, K-T Khaw, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition Endocr. Relat. Cancer, December 1, 2005; 12(4): 1071 - 1082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Geisler and P. E. Lonning Aromatase Inhibition: Translation into a Successful Therapeutic Approach Clin. Cancer Res., April 15, 2005; 11(8): 2809 - 2821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Wang, F. Paris, C. S. Sultan, R. X.-D. Song, L. M. Demers, B. Sundaram, J. Settlage, S. Ohorodnik, and R. J. Santen Recombinant Cell Ultrasensitive Bioassay for Measurement of Estrogens in Postmenopausal Women J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1407 - 1413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Lonning Exemestane for Breast Cancer Prevention: A Feasible Strategy? Clin. Cancer Res., January 15, 2005; 11(2): 918s - 924s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Somboonporn and S. R. Davis Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women Endocr. Rev., June 1, 2004; 25(3): 374 - 388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Endogenous Hormones and Breast Cancer Collaborativ Free Estradiol and Breast Cancer Risk in Postmenopausal Women: Comparison of Measured and Calculated Values Cancer Epidemiol. Biomarkers Prev., December 1, 2003; 12(12): 1457 - 1461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Endogenous Hormones Breast Cancer Collaborative Gr Body Mass Index, Serum Sex Hormones, and Breast Cancer Risk in Postmenopausal Women J Natl Cancer Inst, August 20, 2003; 95(16): 1218 - 1226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Han, K. Fukamachi, N. Takasuka, T. Ohnishi, M. Maeda, T. Yamasaki, and H. Tsuda Inhibitory effects of 17{beta}-estradiol and 4-n-octylphenol on 7,12-dimethylbenz[a]anthracene-induced mammary tumor development in human c-Ha-ras proto-oncogene transgenic rats Carcinogenesis, July 1, 2002; 23(7): 1209 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Endogenous Hormones and Breast Cancer Collabor Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective Studies J Natl Cancer Inst, April 17, 2002; 94(8): 606 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. T. Chlebowski, E. Aiello, and A. McTiernan Weight Loss in Breast Cancer Patient Management J. Clin. Oncol., February 15, 2002; 20(4): 1128 - 1143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A Wiseman Breast cancer hypothesis: a single cause for the majority of cases J Epidemiol Community Health, November 1, 2000; 54(11): 851 - 858. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. R. Jefcoate, J. G. Liehr, R. J. Santen, T. R. Sutter, J. D. Yager, W. Yue, S. J. Santner, R. Tekmal, L. Demers, R. Pauley, et al. Chapter 5: Tissue-Specific Synthesis and Oxidative Metabolism of Estrogens J Natl Cancer Inst Monographs, July 1, 2000; 2000(27): 95 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kabuto, S. Akiba, R. G. Stevens, K. Neriishi, and C. E. Land A Prospective Study of Estradiol and Breast Cancer in Japanese Women Cancer Epidemiol. Biomarkers Prev., June 1, 2000; 9(6): 575 - 579. [Abstract] [Full Text]
|
|
|
|
|
|
J. G. Liehr Is Estradiol a Genotoxic Mutagenic Carcinogen? Endocr. Rev., February 1, 2000; 21(1): 40 - 54. [Abstract] [Full Text]
|
|
|
|
|
|
B. Xie, S.W. Tsao, and Y.C. Wong Induction of high incidence of mammary tumour in female Noble rats with a combination of 17ß-oestradiol and testosterone Carcinogenesis, June 1, 1999; 20(6): 1069 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Cauley, F. L. Lucas, L. H. Kuller, K. Stone, W. Browner, S. R. Cummings, and for the Study of Osteoporotic Fractures Research G Elevated Serum Estradiol and Testosterone Concentrations Are Associated with a High Risk for Breast Cancer Ann Intern Med, February 16, 1999; 130(4_Part_1): 270 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zhang, D. P. Kiel, B. E. Kreger, L. A. Cupples, R. C. Ellison, J. F. Dorgan, A. Schatzkin, D. Levy, and D. T. Felson Bone Mass and the Risk of Breast Cancer among Postmenopausal Women N. Engl. J. Med., February 27, 1997; 336(9): 611 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Cauley, F. L. Lucas, L. H. Kuller, M. T. Vogt, W. S. Browner, and S. R. Cummings Bone Mineral Density and Risk of Breast Cancer in Older Women: The Study of Osteoporotic Fractures JAMA, November 6, 1996; 276(17): 1404 - 1408. [Abstract] [PDF]
|
|